Sadiq Naveed, MD

  • 3Articles
  • 33.9KReads
  • 2018–2025Active
  • 11Collaborators
  • 8Citations

About

Sadiq Naveed, MD, is affiliated with Eastern Connecticut Health Network in Manchester, Connecticut. Naveed has published extensively on psychiatric conditions including major depressive disorder, addiction, dementia, neurodevelopmental disorders, and schizophrenia/schizoaffective disorders. Research topics include the use of GLP-1 agonists in psychiatric illnesses, sedation related to lisdexamfetamine trials, and the psychiatric effects of trimethoprim-sulfamethoxazole. Publications span from 2018 to 2025 in Psychiatrist.com and related journals.

Publications

PCC
Efficacy of GLP-1 Agonists in Mental Disorders
Review Article

Efficacy of GLP-1 Agonists in Mental Disorders

June 10, 2025

Current evidence underscores the potential of GLP-1 receptor agonists as a novel therapeutic approach for certain psychiatric disorders, particularly AUDs, depression, and autism-related food behaviors.
, , , et al
PCC
Case Report

Sedation Secondary to a Trial of Lisdexamfetamine

May 23, 2019

Stimulants are often prescribed to treat ADHD. Here, read about a 6-year-old boy with ADHD who developed excessive daytime sleepiness after starting lisdexamfetamine.
, , , et al
PCC
Letter to the Editor

Trimethoprim-Sulfamethoxazole-Induced Exacerbation of Anxiety and Depression

August 9, 2018

Trimethoprim-sulfamethoxazole is a broad-spectrum antibiotic prescribed for the treatment of uncomplicated infections. Neuropsychiatric side effects are rare but are more common in elderly and immunocompromised patients. Here, read about...
, ,

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe